However, the transformation of regulatory landscape in countries such as Japan and South Korea has made these regions as attractive destinations for the development of stem cell therapy
ATHX) will support a Phase 2a clinical study evaluating the administration of MultiStem cell therapy
to acute respiratory distress syndrome (ARDS) patients.
as an industry is growing due to the demand for cellular therapeutics which can offer treatment or cure to some of the conditions which are not easily treated using biopharmaceutical or drug-based approaches.
Regulatory and ethical issues involving cell therapy
are important and are discussed.
Through this collaboration, Medinet aims to establish immune cell therapy
as evidence-based medicine (EBM) and put it into practical use.
adds weight to the scientific view that cell therapy
is futile as a treatment for Down's syndrome.
The North American region is expected to command the largest share in the stem cell therapy
market in 2016.
In 2015, North America will hold the largest share of the global stem cell therapy
The global stem cell therapy
market is segmented by treatment type into allogeneic and autologous stem cell therapy
technologies and methods have already started to play an important role in the practice of medicine.
Common Cell Therapy
Focus Brings Industry Leaders into Collaboration
OTCBB:PLRS), a cell therapy
company dedicated to the commercialization of stem cell products, today announced that it has engaged William R.